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Expression of the ctx and tcp genes, which encode cholera toxin and the toxin coregulated pilus, the Vibrio
cholerae O1 virulence determinants having the largest contribution to cholera disease, is repressed by the
nucleoid-associated protein H-NS and activated by the AraC-like transcriptional regulator ToxT. To elucidate
the molecular mechanism by which H-NS controls transcription of the ctxAB operon, H-NS repression and
binding were characterized by using a promoter truncation series, gel mobility shift assays, and DNase I
footprinting. Promoter regions found to be important for H-NS repression correlated with in vitro binding.
Four main H-NS binding regions are present at ctx. One region overlaps the high-affinity ToxT binding site and
extends upstream, another overlaps the ToxT low-affinity binding site around the 35 element, and the
remaining two are located adjacent to one another downstream of the transcriptional start site. Competition
for binding to the overlapping H-NS/ToxT binding sites was observed in gel mobility shift assays, where ToxT
was found to displace H-NS from the ctx promoter region. In addition, regulatory differences between the ctx
and tcpA promoters were examined. H-NS was found to have a higher relative binding affinity for the ctx
promoter than for the tcpA promoter in vitro. In contrast to ToxT-dependent activation of the tcpA promoter,
ToxT activation of ctx did not require the C-terminal domain of the -subunit of RNA polymerase. These
findings demonstrate that transcriptional regulation of ctx and tcpA by H-NS and ToxT is mechanistically
distinct, and this may lead to important differences in the expression of these coregulated genes.
Vibrio cholerae is the etiological agent of the human diar-
rheal disease cholera. Two virulence factors that are produced
by V. cholerae and are essential for disease are toxin-coregu-
lated pilus (TCP) (62) and cholera toxin (CT) (28). TCP is a
type IV pilus that is assembled by polymerization of the pilin
subunit, TcpA, and forms long filaments that laterally associate
into bundles. Expression of TCP in vitro results in autoagglu-
tination of the bacterium, and TCP-mediated bacterium-bac-
terium interactions in vivo facilitate microcolony formation on
the intestinal epithelium. Pilus biogenesis requires at least 9
other proteins in addition to TcpA, which are encoded in an
operon located on the Vibrio pathogenicity island (VPI). The
pilus biogenesis apparatus plays a second role in colonization
by secreting the cotranscribed, soluble colonization factor
TcpF, which is also essential for colonization but for which a
mechanism remains unknown (29, 30). The second main viru-
lence factor, CT, is a potent A1B5 subunit, ADP-ribosylating
toxin that is responsible for the severe watery diarrhea that is
associated with cholera. CT is encoded by the ctxAB operon,
which is located on the lysogenic bacteriophage CTX. The
VPI and CTX were both acquired by horizontal gene trans-
fer. TCP serves as the high-affinity receptor for CTX that
links TCP production to ctx acquisition (64).
Expression of the genes encoding TCP and CT in V. cholerae
is controlled by a complex regulatory cascade that is influenced
by both specific regulators, such as ToxR/S, TcpP/H, and ToxT,
and global regulators, such as cyclic AMP (cAMP)-cAMP re-
ceptor protein (CRP), H-NS, and IHF (for reviews, see refer-
ences 7 and 58). The cascade is initiated by two proteins en-
coded within the ancestral chromosome, AphA and AphB,
functioning synergistically to activate transcription of tcpPH
(31, 59). TcpP and TcpH (4, 18) are transmembrane proteins
encoded on the VPI that, along with a second pair of trans-
membrane proteins that are encoded on the ancestral chromo-
some, ToxR and ToxS (42, 43), activate transcription at the
toxT promoter (20, 34). ToxT directly activates expression of
many genes on the VPI, including the biosynthetic genes for
TCP (5, 9, 24, 72) and the accessory colonization factor (ACF)
genes acfA and acfD (52, 68) and aldA (67). ToxT autoregu-
lates its own expression through activation of the upstream
tcpA promoter and readthrough into toxT (71). Additionally,
ToxT regulates some genes that are not encoded on the VPI,
including the ctxAB operon, which encodes the subunits of CT
(9). ToxT therefore functions to coordinately regulate viru-
lence gene expression in V. cholerae by activating genes en-
coded on both the VPI and the CTX element in response to
environmental cues.
ToxT is a member of the AraC/XylS family of transcriptional
regulators (21, 49). The binding sites of many AraC family
members are adjacent to, or overlap, the 35 region of pro-
moters. Interactions between AraC family members and RNA
polymerase (RNAP) have been demonstrated in various sys-
tems (1, 13, 16, 22, 23, 25, 27, 40, 66). ToxT binding sites have
been identified at the tcpA and ctx promoters as well as at the
promoter regions between the divergently transcribed aldA-
tagA and acfA-acfD genes (24, 67, 68, 72). A 13-bp consensus
ToxT binding motif, or toxbox (yrTTTTwwTwAww, where r
can be either A or G, w can be either A or T, and y can be
either C or T), has been proposed by Withey and DiRita based
on the characterized ToxT binding sites (69). The toxbox is
found as a direct repeat at the ctx and tcpA promoters, but the
orientation and distance of the toxbox from the 35 differ
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between these two promoters (Fig. 1A and B). ToxT, like other
AraC/XylS family members, is proposed to interact with the
C-terminal domain (CTD) of the -subunit of RNAP (-CTD)
at the tcpA promoter, since ToxT-dependent activation of tcpA
requires the -CTD (24). It is unknown if the -CTD of RNAP
is important at other ToxT-regulated promoters. Given the
diversity of toxbox arrangements at ToxT-regulated promoters
(69), it is likely that ToxT may form various promoter-specific
interactions with RNAP subunits.
Bacterial virulence gene expression is controlled by complex
and overlapping regulatory systems encoded on pathogenicity
islands, plasmids, and elsewhere within the genome. The nu-
cleoid-associated protein H-NS is an abundant global regulator
that influences various cellular processes (10, 11, 45), including
virulence gene expression in many pathogens. Recent studies
have contributed to our understanding of how this DNA bind-
ing protein with relatively low sequence specificity recognizes
DNA. Whole-genome analysis of H-NS binding sites in Esch-
erichia coli and Salmonella enterica serovar Typimurium re-
vealed that H-NS preferentially binds intrinsically curved, AT-
rich DNA often associated with horizontally acquired elements
(15, 39, 46, 50). It has been suggested that H-NS may serve to
silence genes located on these elements, such as virulence
genes, until dedicated transcription factors or the promoters
themselves can evolve to relieve H-NS repression. H-NS is
thought to silence transcription by directly interfering with
RNAP action or blocking specific activators at nearby pro-
moter regions. H-NS has recently been proposed to bind to
high-affinity nucleation sites with the 10-bp consensus motif
TCGATAAATT and subsequently polymerize along AT-rich
DNA to silence regions of the chromosome (2, 35).
H-NS has been shown to function at multiple promoters
within the virulence regulon to reduce virulence gene expres-
sion under particular environmental conditions (14, 33, 47, 60,
72). H-NS is a repressor of toxT, tcpA, and ctx expression (47).
A variety of data indicate that H-NS directly influences tran-
scription at each of these promoters but that the level of H-NS
repression varies. We have recently shown that V. cholerae
H-NS directly binds the tcpA promoter and that H-NS binding
overlaps the AT-rich ToxT binding site as well as an upstream
IHF binding site (60). The overlapping H-NS/ToxT binding
site at the tcpA promoter suggests that ToxT alleviates H-NS
repression at tcpA in addition to interacting with the -CTD of
RNAP to activate transcription (24). Direct H-NS binding to
the ctx promoter has not yet been demonstrated but is sug-
gested by genetic studies at this promoter (47, 72).
Expression of tcpA and ctx are both activated by ToxT and
repressed by H-NS. However, it seems that ToxT-dependent
FIG. 1. Organization of the tcpA and ctx promoters. Base pair sequences of the ctx (A) and tcpA (B) promoter fragments relative to their
transcriptional start sites (1) are shown. The core promoter 10 and 35 elements are underlined. The promoter regions protected by
ToxT from DNase I (72) are denoted by solid gray bars above the sequence. At ctx, the low-affinity (L; light gray) and high-affinity (H; dark gray)
ToxT binding sites are shown. The low-affinity sites are those that require higher concentrations of ToxT to show protection (72). Proposed ToxT
consensus sites, toxboxes, are indicated by arrows, and the consensus toxbox sequence is shown in panel C, where r  A/G, w  A/T, and y  C/T.
(C) The IHF consensus site centered at 162 of tcpA is indicated by a black bar. Putative H-NS nucleation sites with seven or more matches to
the 10-bp H-NS consensus (35) are indicated in boldface letters.
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activation and H-NS-dependent repression are mechanistically
distinct at these promoters. H-NS represses basal ctx expres-
sion to a greater extent than tcpA expression (47, 72). Yu and
DiRita also showed that the ToxT binding site at ctx is of
higher affinity than the ToxT site at tcpA (72). In addition,
characterization of the in vivo temporal expression pattern in
the El Tor biotype of V. cholerae revealed that the coordinately
regulated tcpA and ctx genes are actually sequentially ex-
pressed in the infant mouse model of cholera (36). Expression
of tcpA initiates 2 h prior to ctx expression in vivo.
MATERIALS AND METHODS
Bacterial strains and growth. The V. cholerae and E. coli strains and plasmids
used in this study are listed in Table 1. Strains were maintained at 70°C in
Luria-Bertani (LB) medium (41) containing 30% (vol/vol) glycerol. Antibiotics
were used at the following concentrations in LB medium: ampicillin (Ap), 100
g/ml; chloramphenicol (Cm), 30 g/ml; streptomycin (Sm), 1 mg/ml; tetracy-
cline (Tc), 15 g/ml. 5-Bromo-4-chloro-3-indolyl--D-galactopyranoside (X-Gal)
was used in LB agar at 40 g/ml (Sigma). Arabinose was added to the growth
medium at a final concentration of 0.02%.
Strain and plasmid construction. The E. coli (ctx-lacZYA)1 fusion was con-
structed by amplifying the O395 ctx promoter region from 522 to 114, with
respect to the transcriptional start site, using primers MN37 and MN42 (Table
2). The resulting fragment was cloned into pRS415 to generate pMIN46. The
(ctx-lacZYA)1 fusion was recombined onto RS45 (56) and integrated into the
chromosome of MC4100 to create MBN425. Similarly, the E. coli (ctx-lacZYA)2
fusion was constructed by amplifying the ctx promoter region from 202 to 114
using primers MN34 and MN37. The MN34/MN37 fragment was cloned into
pRS415, generating pRHK1. The (ctx-lacZYA)2 fusion was recombined onto
RS45 and integrated into the chromosome of MC4100 to create MBN410. The
E. coli (ctx-lacZYA)3 fusion was constructed by amplifying the ctx promoter
region from 118 to 114 using primers MN35 and MN37. The MN35/MN37
fragment was cloned into pRS415, generating pRHK2. The (ctx-lacZYA)3 fusion
was recombined onto RS45 and integrated into the chromosome of MC4100 to
create MBN392. The E. coli (ctx-lacZYA)4 fusion was constructed by amplifying
the ctx promoter region from 65 to 114 using primers MN36 and MN37. The
MN36/MN37 fragment was cloned into pRS415, generating pRHK3. The (ctx-
lacZYA)4 fusion was recombined onto RS45 and integrated into the chromo-
some of MC4100 to create MBN412.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Characteristic(s) Reference or source
V. cholerae strains
O395 Sm Classical Ogawa, Smr 62
KSK218 CG842 ctx-lacZ 57
MBN019 KSK218 	toxT 47
MBN153 MBN019 	hns1 47
E. coli strains
ER2566 Expression strain, T7 RNA polymerase New England Biolabs
BL21(DE3) Expression strain, hsdS gal ( imm21 nin5 lacuv5-T7 gene 1) (rB
 mB
) Lab collection
MC4100 F araD139 	(argF-lac)U169 rpsL150 relA1 flbB5301 deoC1 ptsF25 rbsR, Smr 55
DL1976 MC4100 hns651, Tcr 65
MBN425 MC4100 (ctx-lacZYA)1, (522/114) This work
MBN426 MBN425 hns651, Tcr This work
MBN410 MC4100 (ctx-lacZYA)2, (202/114) This work
MBN411 MBN410 hns651, Tcr This work
MBN392 MC4100 (ctx-lacZYA)3, (118/114) This work
MBN408 MBN392 hns651, Tcr This work
MBN412 MC4100 (ctx-lacZYA)4, (65/114) This work
MBN424 MBN412 hns651, Tcr This work
Plasmids
pRS415 lacZYA transcriptional fusion vector 56
pMIN46 pRS415::(ctx-lacZYA)1, Apr 48
pRHK1 pRS415::(ctx-lacZYA)2, Apr This work
pRHK2 pRS415::(ctx-lacZYA)3, Apr This work
pRHK3 pRS415::(ctx-lacZYA)4, Apr This work
pBAD22 Expression vector, Apr 17
pBlueScript Cloning vector, Apr Stratagene
pBS-ctx pBlueScript, 316-bp ctx promoter fragment (202/114) This work
pTXB-1 Expression vector for intein/chitin binding domain fusion, Apr New England Biolabs
pEAS10 pTXB-1, hns Apr 60
pRH81 pBAD22, 6His toxT 24
pACYC184 Expression plasmid, Cmr 6
pTSS-5 pACYC184 toxT, Cmr 3
pMMB66EH Expression plasmid, Apr 12
pRH170 Full-length rpoA in pMMB66EH 24
pRH171 rpoA	235 in pMMB66EH 24











a All oligonucleotides are shown 5
 to 3
. Underlined portions indicate se-
quences encoding relevant restriction sites.
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The hns651 mutation from DL1976 was transduced into each of the E. coli
ctx-lacZYA fusion strains by using P1vir. Resultant strains were confirmed to be
deficient for hns by PCR and by salicin utilization on MacConkey medium
supplemented with 0.5% salicin.
-Galactosidase assays. -Galactosidase activity was determined by the
method of Miller (41) with the following modifications. E. coli strains harboring
ctx-lacZ lysogens were assayed for -galactosidase activity after growth to mid-
log phase in LB medium at 30°C and shaking. Due to TCP-mediated bacterial
autoagglutination, the specific activity of strains in the KSK218 background (V.
cholerae ctx-lacZ) was calculated using the protein concentration determined by
a bicinchoninic acid procedure (Pierce) rather than by using the more standard
optical density normalization.
Purification of H-NS and ToxT. H-NS was purified from the E. coli strain
ER2566 containing the V. cholerae hns expression plasmid pEAS10 by using the
IMPACT-CN system as previously described (60). Briefly, the cells were grown
in LB Amp at 37°C, and hns expression was induced with isopropyl--D-thioga-
lactopyranoside (IPTG) overnight at 16°C, the culture was centrifuged, soni-
cated, recentrifuged, and the supernatant was loaded onto a chitin column. The
chitin binding domain was cleaved off H-NS by using dithiothreitol (DTT), H-NS
was eluted off the column, and the protein was dialyzed overnight in 20 mM Tris
(pH 8.0), 1 mM EDTA (pH 8.0), 5 mM potassium glutamate, and 0.1 mM DTT.
Purified protein was stored at 70°C in 10% glycerol.
ToxT protein was purified essentially as previously described (24). Briefly,
BL21 cells containing the 6His-ToxT expression plasmid pRH81 were grown at
37°C to mid-log phase, arabinose was added to a final concentration of 0.02%,
and growth was continued at 12°C for an additional 12 h. Cell pellets were
resuspended in extraction buffer (50 mM sodium phosphate, 300 mM NaCl; pH
7.0) and lysed by sonication. Following a clarifying spin at 12,000 rpm in a Sorvall
SS34 rotor for 30 min, the supernatant was passed over Talon metal affinity resin
(Clontech), washed with extraction buffer containing 20 mM imidizole, and ToxT
was then eluted from the column with extraction buffer containing 200 mM
imidazole. ToxT-containing fractions were pooled and dialyzed against TEN
buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA [pH 8.0], 150 mM NaCl)
containing 1 mM DTT. Protein was stored at 70°C in 10% glycerol.
The purity of the proteins was 90% as determined densitometrically after
separation by SDS-PAGE and staining with Coomassie blue. The Bradford
method was used to determine the concentration of H-NS and 6His-ToxT in
relation to a standard curve for bovine serum albumin (BSA). The concentra-
tions were not corrected for potential differences in dye reactivity between the
purified proteins and BSA.
Gel mobility shift assays. DNA fragments of the tcpA and ctx promoter regions
were generated by PCR from V. cholerae O395 chromosomal DNA with the
oligonucleotide pairs MN42/ctx42R (C1; 522 to 178), ctxE1/MN37 (C2; 202
to 114), MN35/MN37 (C3; 112 to 114), and MN36/MN37 (C4; 65 to
114) for ctx and TCP-SAL/TCP-XHO (tcp; 226 and 78) for tcpA. H-NS gel
mobility shift assays were carried out in a volume of 20 l containing DNA
binding buffer (40 mM HEPES, 100 mM potassium glutamate, 10 mM magne-
sium aspartate, 0.022% NP-40, 100 g/ml BSA, 10% glycerol), 10 ng of digoxi-
genin (DIG)-labeled DNA, 1 g of calf thymus DNA, and purified H-NS. After
incubation at room temperature for 20 min, protein-DNA complexes were sep-
arated by 5% nondenaturing polyacrylamide gel electrophoresis in 0.5 Tris-
EDTA (TE) buffer at 4°C and transferred to nylon. DNA was visualized with an
anti-DIG detection kit (Roche) followed by enhanced chemiluminescence de-
tection.
ToxT gel mobility shift assays were carried out in a 20-l mixture containing
DNA binding buffer (10 mM Tris [pH 7.5], 100 mM KCl, 1 mM EDTA [pH 8.0],
1 mM DTT, 10% glycerol, 300 mg/ml BSA), 10 ng of DIG-labeled DNA, 1.5 g
of calf thymus DNA, and purified 6His-ToxT. After incubation at 30°C for 15
min, protein-DNA complexes were separated on 5% nondenaturing polyacryl-
amide gels in 0.5 TE buffer at 4°C and visualized as described above.
DNase I footprinting. A ctx promoter fragment was amplified from O395
chromosomal DNA with primer pair ctxE1/MN37 (202 to 114). The fragment
was ligated into pBlueScript (Stratagene), generating pBS-ctx. Fragments for
labeling were cut from pBS-ctx by restriction digestion with EcoRI and BamHI.
Strand labeling was carried out essentially as described by Kovacikova and
Skorupski (32). Binding reactions were performed in 6.5 l with 33P-end-labeled
DNA, purified H-NS, and binding buffer as described above. After incubation at
30°C for 15 min, protein-DNA complexes were digested with 1 l of various
dilutions of DNase I (Promega) for 5 min at 30°C. Reactions were stopped in 2
mM EGTA followed by heat inactivation at 65°C for 10 min and then spot
dialyzed for 30 min against 10 mM Tris (pH 8.0), 0.1 mM EDTA. They were then
heated to 90°C for 5 min in formamide loading buffer (Epicentre) and separated
on a 6% polyacrylamide sequencing gel in 1 TBE at ambient temperature. Gels
were dried and visualized by autoradiography.
RESULTS
H-NS repression utilizes heptad repeats within the ctx pro-
moter. Characteristics of the ctx promoter that potentially fa-
vor a direct interaction of H-NS include a high AT content
over the promoter as well as regions of predicted curvature
(data not shown). In addition, scanning of the ctx promoter for
putative H-NS nucleation sites using the 10-bp consensus iden-
tified by Lang et al. (35) revealed five sites with greater than
seven matches to the consensus binding site, TCGATAAAT
(Fig. 1A, bold sequences). The ctx promoter also contains a
region of notably high AT content (86%) composed of seven
tandem repeats of the sequence TTTTGAT (Fig. 1A, boxes).
The heptad repeat sequences have previously been shown as
binding sites for the transcriptional activators of ctx, ToxR (37,
43, 53), and ToxT (5, 71). It was hypothesized that H-NS may
bind to this repeat region of the ctx promoter utilized by the
transcriptional activator proteins and that occupation of these
sites by H-NS could prevent ctx activation.
To genetically determine the region required for H-NS reg-
ulation of this promoter, a series of ctx-promoter lacZ fusions
containing various lengths of promoter DNA were constructed
in the plasmid pRS415 (Fig. 2A). These fusions were inte-
grated as single lambda lysogens in the E. coli chromosome,
and the expression from each was measured based on -galac-
tosidase activity in the presence and absence of hns. The three
longest constructs, C1, C2, and C3, had low and equivalent
basal levels of -galactosidase activity in the presence of the
wild-type hns allele (Fig. 2A). The corresponding hns-deficient
strains were highly derepressed, with the degree of induction
ranging from 16- to 23-fold. As expected, expression from each
of these three fusions could be activated by the presence of a
plasmid encoding ToxT (pMT5) (data not shown). The short-
est construct, C4, lacks six of the seven TTTTGAT sites (Fig.
2A). In the presence of hns, C4 had a 4- to 6-fold increase in
expression compared to the three longer fusions (Fig. 2A).
This increase in expression suggests that H-NS may bind to the
repeats to repress ctx expression. Additional derepression of
the C4 fusion was achieved in the absence of hns, suggesting
that sites remaining within this short fusion (65 to 114) also
contribute to repression by H-NS. The shortest fusion was not
activated in the presence of ToxT (data not shown), which is
consistent with the known binding sites for each of these acti-
vators (24, 72). By truncating the promoter distal sequence, we
were able to show that the region containing the TTTTGAT
sites, previously implicated in ToxR and ToxT binding, also
contributes to H-NS-mediated repression of ctx expression and
that H-NS repression still occurs on the 65/114 region
of ctx.
Direct binding of H-NS to the ctx promoter. Gel mobility
shift assays (Fig. 2B) were performed to examine if regions
identified as important for H-NS repression (Fig. 2A) were
also important for H-NS binding at the ctx promoter. Specific
binding of H-NS to the ctx promoter region was examined on
promoter fragments that were constructed based on the pro-
moter truncation series in Fig. 2A. Fragment CU (upstream
region) extends from 522 to 178 of the C1 promoter fusion
982 STONEHOUSE ET AL. J. BACTERIOL.
and was used to monitor H-NS binding to this upstream region.
Fragments C2, C3, and C4 correspond to the promoter fusions
in Fig. 2A. Each of the DNA fragments was incubated with 180
or 360 nM purified V. cholerae H-NS, and the samples were
analyzed on native polyacrylamide gels. H-NS binding was
observed on the C2, C3, and C4 promoter fragments (Fig. 2C),
but not on the CU fragment (Fig. 2B). H-NS binding was
decreased on the C4 fragment, where only one heptad repeat
remains compared to the C3 and C2 fragments. These results
are consistent with expression data in Fig. 2A, which showed
that H-NS has a greater repressive effect on the C2 and C3
fragments than the C4 fragment (16- versus 8.5-fold) and con-
firmed that the heptad repeats are involved in H-NS binding to
the ctx promoter.
H-NS protects the ToxT binding site, 35, and promoter
distal regions from DNase I at ctx. DNase I footprinting was
used to determine the location of H-NS binding within the ctx
promoter. Radiolabeled fragments were generated that
spanned the ctx promoter region from 202 to 114 (Fig. 2A,
construct C2). Fragments were incubated with increasing
amounts of H-NS and digested with DNase I as described in
Materials and Methods. The reactions were then subjected to
electrophoresis on a denaturing polyacrylamide gel. H-NS pro-
tection was widespread over the ctx promoter region (Fig. 3).
Four main regions of H-NS protection were identified: one
overlapping the high-affinity ToxT binding site and extending
upstream, one overlapping the ToxT low-affinity binding site
and the 35 element, and two adjacent regions downstream of
the transcription start (Fig. 3; see also Fig. 1). These results
indicate that H-NS binding overlaps the binding sites of ToxT
and RNAP at the ctx promoter. The overlapping H-NS and
ToxT binding sites suggest that ToxT might displace H-NS in
order to bind the ctx promoter and recruit RNAP to activate
transcription.
Competition of ToxT with H-NS at the ctx promoter. It was
hypothesized that displacement of H-NS by ToxT at the ctx
promoter region is essential for transcriptional activation of
the toxin genes, since ToxT protein levels increase while H-NS
levels do not change under the transition to inducing condi-
tions (data not shown). Competitive gel mobility shift assays
were performed between H-NS and ToxT on the ctx promoter
region to examine the effect of adding ToxT to prebound
H-NS–DNA complexes. The DNA was incubated in ToxT
binding buffer with a low (165 nM) or high (330 nM) concen-
tration of H-NS that gave a partial or complete shift of the free
DNA, respectively. After 15 min at 30°C, increasing amounts
of ToxT (0.9, 1.8, and 3.6 M) were added to free DNA or
H-NS-prebound DNA, and incubation was continued for an
additional 15 min. When ToxT was incubated alone with DNA,
the ToxT-DNA complexes (lanes 4 to 6) migrated as diffuse
bands that tightened to a distinct band at the highest ToxT
concentration. Given the large region of DNase I protection by
ToxT at ctx that could accommodate two to four ToxT mono-
mers (Fig. 1A), the diffuse banding pattern may represent
FIG. 2. Promoter truncation analysis at ctx. (A) Schematic repre-
sentations of the extent of the ctx promoter present in each fusion
construct are shown to the left. Gray rectangles each represent one
reiteration of the heptad repeat 5
-TTTTGAT-3
. Culture of E. coli
strains that are either hns or hns deficient (hns651) and carry a
chromosomal copy of each fusion construct were grown to mid-log
phase in LB medium at 30°C with shaking and assayed for -galacto-
sidase production. Data are expressed in Miller units and the standard
deviation. The fold derepression was calculated as the increase in
-galatosidase activity in the hns-deficient strain compared to the hns
strain. (B and C) DIG-labeled ctx promoter fragments from 522 to
178 (CU), 202 to  114 (C2), 118 to  114 (C3), and 65 to 
114 (C4). Fragments were incubated with purified H-NS and analyzed
on a nondenaturing polyacrylamide gel. The first lane in each set has
no protein added, the second lane contains 180 nM H-NS, and the
third lane contains 360 nM H-NS.
FIG. 3. DNase I protection by H-NS at the ctx promoter. The top
and bottom strands of the ctx promoter fragments were incubated with
increasing amounts of purified H-NS (0.25, 0.5, 1, and 2 M) and
treated with DNase I. Regions protected from DNase I cleavage by
H-NS are shown by black bars. The ToxT high-affinity site protected
from DNase I cleavage (72) is shown by a gray bar. White boxes
represent the seven repeats of the heptad sequence 5
-TTTTGAT-3
.
Open rectangles to the right represent the positions of the 10 and
35 hexamers. In each gel, a GA DNA sequencing ladder is shown.
The numbering is relative to the transcription start site.
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various ToxT-DNA species with different sites occupied. Al-
ternatively, ToxT may bend the ctx promoter and contribute to
differences in migration in the gel. However, ToxT-induced
bending of the ctx promoter was not observed when we used a
circular permutation assay, which allows visualization of pro-
tein-induced DNA bending in a standard gel mobility shift
assay (data not shown). A more compact migrating species was
observed upon addition of 0.9 and 1.8 M ToxT to a prebound
H-NS fragment compared to these ToxT concentrations alone
(Fig. 4A, compare lanes 7, 8, 10, and 11, containing H-NS, to
lanes 4 and 5, containing just ToxT). These distinct H-NS/
ToxT–DNA bands suggest that H-NS and ToxT can simulta-
neously occupy the DNA when ToxT concentrations are rela-
tively low. The condensed banding pattern also suggests that
the presence of H-NS on the DNA may facilitate a more
ordered binding of ToxT to the promoter fragment. The ability
of H-NS to bend the ToxT binding site or interact with ToxT
was investigated in order to understand how H-NS could affect
ToxT binding. A circular permutation assay with H-NS and the
ctx promoter and a bacterial two-hybrid experiment investigat-
ing H-NS and ToxT protein interactions suggested that H-NS
did not bend the ctx promoter fragment or directly interact
with ToxT (data not shown). Addition of 3.6 M ToxT to
prebound H-NS–DNA complexes (165 or 330 nM H-NS) re-
sulted in a shift to a predominately ToxT-DNA complex (com-
pare lanes 9 and 12, containing H-NS and ToxT, to lane 6,
containing just ToxT). These results suggest that at low levels
of ToxT, H-NS and ToxT can both be bound to the DNA,
while at high levels of ToxT, ToxT displaces H-NS.
Competition of H-NS and ToxT at the ctx promoter. Com-
petition of H-NS for ToxT-prebound DNA was also inves-
tigated in competitive gel mobility shift assays. DNA was
incubated with ToxT followed by addition of H-NS to the
ToxT-DNA prebound complexes. ToxT at 1.8 and 3.6 M
was incubated with the ctx promoter fragment (Fig. 4B,
lanes 2 and 3). Addition of increasing amounts of H-NS to the
1.8 M ToxT-DNA complexes (lanes 7 to 9) resulted in a shift
that was more retarded in migration than with 1.8 M ToxT
alone (lane 2) or H-NS alone (lanes 4 to 6). This banding
pattern suggested that H-NS was able to bind the ToxT-DNA
complex at low levels of ToxT but was unable to displace ToxT
from the DNA. Addition of H-NS to DNA incubated with 3.6
M ToxT (lanes 10 to 12) did not alter the migration of the
ToxT-DNA species (lane 3), suggesting that at high ToxT lev-
els H-NS is unable to displace ToxT from the DNA and may
not be able to bind to the promoter fragment, even at sites
downstream or upstream of the ToxT binding region.
H-NS has a higher relative affinity for the ctx promoter than
the tcpA promoter. H-NS represses the transcription of both ctx
and tcpA. Genetic studies have shown that H-NS repression is
greater at ctx than tcpA (47, 72). We previously showed direct
binding of H-NS at the tcpA promoter (60). Gel mobility shift
assays were used to investigate if the differences in H-NS
repression between the two virulence promoters correlated
with differences in H-NS binding to the promoters. Promoter
fragments from ctx (C2, 202 to 114) and tcpA (225 to
78) were incubated with increasing amounts of H-NS to
measure the relative binding affinity of H-NS for the two pro-
moters. H-NS bound to both the ctx and tcpA promoter frag-
ments (Fig. 5A). Comparison of the shifting of the ctx and tcpA
promoter fragments in the presence of equimolar H-NS re-
vealed that H-NS bound with higher affinity to the ctx pro-
moter fragment than to the tcpA promoter fragment. The ctx
fragment was completely shifted in the presence of 0.66 M
H-NS, whereas the tcpA fragment was not fully shifted at 0.66
M H-NS but required 1.32 M H-NS to completely shift the
free DNA (Fig. 5A). To further examine the differential bind-
ing affinities of H-NS for these promoter regions, increasing
amounts of H-NS were incubated with a mixture of equimolar
ctx and tcpA promoter fragments (Fig. 5B). The ctx fragment is
13 bp longer and migrates slower in the gel than the tcpA
fragment. A full shift of the free ctx fragment was observed at
a lower H-NS concentration (0.66 M) than was the free tcpA
fragment (2.6 M). These results demonstrate that H-NS has
a higher relative binding affinity for the ctx promoter than for
the tcpA promoter, and it is possible that this may contribute to
differences in H-NS-mediated repression of these virulence
genes.
ToxT does not require -CTD of RNA polymerase to acti-
vate transcription at ctx. Yu and DiRita (72) determined that
at ctx, ToxT has a higher affinity for its binding site than it does
at tcpA. In addition, they found that ToxT stimulated RNAP
transcriptional activation at both promoters, suggesting that
ToxT functions not only to overcome H-NS repression from
shared binding sites but also by interacting with RNAP. Many
AraC family members require the -CTD of RNA polymerase
FIG. 4. Interaction of H-NS and ToxT with ctx promoter DNA. Competitive gel mobility shift assays were carried out with the ctx promoter
fragment (C2; 202 to 114) by combining various amounts of H-NS and ToxT. (A) Fixed amounts of H-NS with increasing levels of ToxT. H-NS
was added at 0 (lanes 1 and 4 to 6), 0.165 (lanes 2 and 7 to 9), and 0.33 M (lanes 3 and 10 to 12), followed by addition of ToxT at 0 (lanes 1
to 3), 0.9 (lanes 4, 7, and 10), 1.8 (lanes 5, 8, and 11), and 3.6 M (lanes 6, 9, and 12). (B) Fixed amounts of ToxT with increasing levels of H-NS.
ToxT was added at 0 (lanes 1 and 4 to 6), 1.8 (lanes 2 and 7 to 9), and 3.6 M (lanes 3 and 10 to 12), followed by addition of H-NS at 0 (lanes
1 to 3), 0.165 (lanes 4, 7, and 10), 0.33 (lanes 5, 8, and 11), and 0.66 M (lanes 6, 9, and 12).
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to activate transcription at their respective promoters (23, 25,
26, 40, 54). We previously reported a requirement for the
-CTD of RNA polymerase in ToxT-dependent activation at
the tcpA promoter (24), where the ToxT binding site extends
from 84 to 41 (Fig. 1B). In contrast, the ctx promoter may
be a class II ToxT-dependent promoter due to the ToxT bind-
ing site overlapping the 35 determinant for RNAP. To de-
termine if the -CTD of RNA polymerase is required for
ToxT-dependent activation at ctx, we performed the same ge-
netic analysis that had been used at tcpA and that was based on
a method described by Holcroft and Egan (23). Expression of
ctx-lacZ was monitored upon expression of a truncated rpoA
gene (	235 rpoA) that encodes an -subunit that is missing the
C-terminal domain. The truncated -subunit has a dominant
negative effect at promoters that require the -CTD of RNAP
for activation. This is based on previous experiments per-
formed in E. coli (19) as well as our results for tcpA activation
in V. cholerae and E. coli (24). A full-length rpoA was also
expressed for comparison. The full and truncated rpoA con-
structs were introduced into V. cholerae strains carrying a chro-
mosomal ctx-lacZ fusion. In the wild-type background, expres-
sion of the truncated -subunit upon addition of IPTG
resulted in a 7.5-fold decrease in ctx-lacZ expression compared
to expression of the full-length -subunit (Fig. 6A). This effect
was not seen in a 	toxT or a 	toxT 	hns background, which
was used to increase the basal level of promoter activity in the
absence of ToxT. These results suggest that ToxT-dependent
transcription, and not basal transcription of ctx-lacZ, depends
on the -CTD of RNAP. Since ToxT autoregulates its own
expression from the upstream tcpA promoter, it is likely that
toxT expression itself is decreased upon expression of the trun-
cated -subunit of RNAP. To test if the decrease in ctx-lacZ
expression is due to a direct effect of the truncated -CTD at
ctx and not due to altered toxT expression, ToxT was expressed
from the -CTD-independent tetR promoter by using plasmid
pTSS-5. These experiments were carried out in E. coli, since
the tetR promoter is not expressed well in V. cholerae. The E.
coli ctx-lacZ strain (522/114; MBN425) carrying IPTG-
inducible full-length rpoA or 	235 rpoA on pMMB66EH and
pTSS-5 as a source of ToxT was assayed by performing -ga-
lactosidase assays. It was found that when ToxT was expressed
from an -CTD-independent promoter, there was only a slight
loss (1.5-fold decrease) of ToxT-dependent ctx-lacZ expres-
sion upon expression of the truncated -CTD (ToxT;
p235). This suggests that the 7.5-fold defect in ctx-lacZ ex-
pression observed in V. cholerae when ToxT was expressed
from its own promoter was most likely indirect and due to the
role of -CTD in toxT expression levels. In contrast, expression
of the truncated -CTD in E. coli caused a 4-fold defect in
ToxT-dependent activation of the tcpA-lacZ fusion (24). These
results indicate that ToxT interacts with the -CTD of RNAP
to activate transcription of tcpA but not ctx.
DISCUSSION
In this study, a series of in vivo and in vitro experiments were
conducted to elucidate the molecular mechanism by which the
H-NS protein represses transcription of the ctx operon. A
promoter deletion analysis revealed regions that were impor-
tant for H-NS repression and likely H-NS binding. H-NS re-
pression was high (8.5- to 23-fold) for all ctx promoter fusions.
Deleting the sequence between 118 to 65 (C3 to C4), which
included six of the seven heptad repeats, caused the largest loss
in H-NS repression of ctx-lacZ expression (16- versus 8.5-fold)
(Fig. 2A). Since the promoter fusions all included sequence to
114 relative to the site of the start of transcription, it is
FIG. 5. H-NS binding at ctx and tcpA. Results of a gel mobility shift
assay show H-NS binding to the ctx and tcpA promoter fragments.
DIG-labeled ctx (202 to 114) and tcp (225 to 78) promoter
fragments were incubated individually (A) or together (B) with the
indicated amounts of purified H-NS.
FIG. 6. Influence of dominant negative RNA polymerase -subunit
on ctx-lacZ expression in V. cholerae (A) and E. coli (B). (A) Cultures
of V. cholerae harboring ctx-lacZ that were otherwise wild type
(KSK218), 	toxT (MBN019), or 	toxT 	hns (MBN153) carrying plas-
mids expressing either full-length rpoA (pRH170) or truncated 	235
rpoA (pRH171) were grown overnight in LB medium with a starting
pH of 6.5 at 30°C with or without 0.04 mM IPTG. (B) Strains of E. coli
ctx-lacZ (MBN425) carrying plasmids expressing either full-length
rpoA (pRH170) or truncated rpoA (pRH171) in the absence or pres-
ence of the toxT-expressing plasmid pTSS-5 were grown overnight in
LB medium with a starting pH of 6.5 at 30°C with or without 0.04 mM
IPTG. All values are averages of at least two independent experiments.
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possible that H-NS may bind and regulate ctx from regions
downstream of the 1 site. Taken together with the fact that
the region from 1 to 114 of the ctxA gene is approximately
71% AT rich, compared with the entire ctxAB locus at 56%
AT, it is possible that H-NS contributes to the regulation of ctx
from sequences within the gene itself. H-NS has been shown to
regulate gene expression from downstream regulatory ele-
ments in proU, coo, and others, including the eltAB operon,
which encodes the heat-labile enterotoxin of enterotoxigenic
E. coli (44, 51, 70).
Biochemical studies were used to support this genetic anal-
ysis and to identify H-NS binding sites within the ctx promoter.
Based on DNase I footprinting, H-NS binding was found to
overlap the ToxT binding site, 35 element, and two regions
downstream of the 1 site. Thus, we conclude that H-NS
specifically binds the ctx promoter region, supporting a direct
regulatory role for H-NS in ctx gene repression. Given the
regions of protection in DNase I footprinting, it is likely that
H-NS functions to block transcription initiation by interfering
with ToxT and RNAP binding and activation. H-NS may also
function downstream of the transcriptional start site to either
inhibit open complex formation by polymerase or inhibit later
stages of transcriptional initiation/elongation.
Given the high intracellular levels of H-NS which vary little
during bacterial growth, it is likely that the tcp and ctx operons
are normally repressed by H-NS when V. cholerae is not in its
host environment. This effect would be overcome by V. chol-
erae regulatory proteins that, under appropriate environmental
conditions, could act as antirepressors to alleviate the effects of
H-NS on tcp and ctx expression. Indeed, several bacterial reg-
ulatory proteins are known to alleviate H-NS repression by
displacing H-NS from the DNA (8, 38, 61, 63). At the tcpA
promoter we have previously reported that both ToxT and IHF
act as antirepressors of H-NS (60). Here we suggest that ToxT
also acts as an antirepressor of H-NS at ctx by displacement of
H-NS from the promoter (Fig. 4A). Interestingly, at low con-
centrations of ToxT, H-NS still bound the ctx promoter frag-
ment. This suggests that H-NS repression may occur until a
threshold level of ToxT is reached that is able to fully displace
H-NS. In addition, it is possible that the displacement of ToxT
by H-NS is important for reintroducing H-NS repression of
toxin gene transcription when the toxin is no longer required
(e.g., upon dissemination back into the environment). How-
ever, competition experiments suggested that H-NS could not
displace ToxT from the ctx promoter (Fig. 4B). These results
suggest that ctx expression is primarily dependent on ToxT
levels within the cell. The ctx genes may only be repressed as
toxT expression is downregulated or upon turnover of the ToxT
protein, which would allow H-NS access to the promoter.
H-NS has a more moderate repressive effect at the tcpA
promoter than at the ctx promoter (47, 72). Basal levels of ctx
expression increase 10-fold upon deletion of hns, while tcpA
expression increases 6.3-fold in V. cholerae (47). This could
correlate with the in vivo temporal delay between tcpA expres-
sion and ctx expression that has been observed in the infant
mouse model (36). In these studies we found that H-NS had an
almost-2-fold-higher affinity for the ctx promoter than the tcpA
promoter, a difference that is similar to the observed difference
in H-NS repression of these promoters. The greater H-NS
repression at ctx may establish a higher threshold level of ToxT
required to displace H-NS and activate expression of ctx com-
pared to tcpA. In addition, it was previously reported that ToxT
also has a higher affinity for the ctx promoter than for the tcpA
promoter (72). Thus, the delay in ctx expression compared to
tcpA expression may involve more than differing affinities of
H-NS and ToxT for these promoters. Differences in ToxT
activation at these promoters, beyond antirepression of H-NS,
have also been investigated. DNase I protection by ToxT at the
tcpA and ctx promoters (72) (Fig. 1A and B) suggested that the
ctx promoter may be a class II promoter. We found that ToxT-
dependent activation at ctx did not require the -CTD of
RNAP as it does at tcpA (24). This difference in ToxT-RNAP
interactions between the promoters may also contribute to
differences in expression of these coregulated genes under
different environmental conditions.
Virulence factors in many enteric pathogens are negatively
regulated by H-NS. Many of these same factors show positive
regulation by an AraC family member. Even in V. cholerae the
majority of ToxT-activated genes are also repressed by H-NS
(unpublished data). Understanding how these regulatory pro-
teins function at each promoter to coordinate gene expression
will expand our understanding of how proteins, like ToxT,
function to overcome H-NS repression and initiate virulence
gene expression.
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